1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United States >
  6. California >
  7. BioMarin Pharmaceutical >
  8. M&A

BioMarin Pharmaceutical Mergers & Acquisitions

BioMarin Pharmaceutical M&A Summary

BioMarin Pharmaceutical has acquired 3 companies, including 1 in the last 5 years.

BioMarin Pharmaceutical’s largest acquisition to date was in 2014, when it acquired Prosensa for $680M. BioMarin Pharmaceutical has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (67%) and healthcare services (34%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 2

BioMarin Pharmaceutical

BioMarin Pharmaceutical, Inc.

770 Lindaro Street,
San Rafael, California 94901
United States,
(415) 506-6700
www.biomarin.com

All (3) Buy (3) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-05-16 Inozyme Pharma · Life Science
Boston, Massachusetts · www.inozyme.com

Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. The company's lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. It has demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency. Inozyme Pharma was formed in 2015 and is based in Boston, Massachusetts.

Advisors: Centerview Partners , Goodwin Procter 		270 Add-on Acquisition

BioMarin Pharmaceutical
Advisors: Cooley , Goldman Sachs

-

Try Mergr Free — See This and 220,677+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal